Literature DB >> 34963697

Author Correction: Anisomycin prevents OGD-induced necroptosis by regulating the E3 ligase CHIP.

Mi-Bo Tang1,2, Yu-Sheng Li1, Shao-Hua Li1,2, Yuan Cheng1,2, Shuo Zhang1,2, Hai-Yang Luo1,2, Cheng-Yuan Mao1, Zheng-Wei Hu1,2, Jonathan C Schisler3,4, Chang-He Shi5, Yu-Ming Xu6.   

Abstract

Entities:  

Year:  2021        PMID: 34963697      PMCID: PMC8714807          DOI: 10.1038/s41598-021-04253-0

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


× No keyword cloud information.
Correction to: Scientific Reports 10.1038/s41598-018-24414-y, published online 23 April 2018 This Article contains an error in Figure 1A. As a result of a mistake in figure assembly, the band for p-MLKL is incorrect. The correct Figure 1 and accompanying legend appear below.
Figure 1

OGD challenge induces necroptotic cell death. (A–B) Representative western blot, with β-actin used for normalization. RIPK1, RIPK3, p-RIPK3 and p-MLKL in control cells, cells challenged by OGD which were pre-treated with or without Nec-1 (50 μM) were tested. The bars represent the mean ± SEM of five independent experiments. Significant differences *p < 0.05 vs. Control, #p < 0.05 vs. OGD. Related blots are shown in Supplementary Fig. S1.

OGD challenge induces necroptotic cell death. (A–B) Representative western blot, with β-actin used for normalization. RIPK1, RIPK3, p-RIPK3 and p-MLKL in control cells, cells challenged by OGD which were pre-treated with or without Nec-1 (50 μM) were tested. The bars represent the mean ± SEM of five independent experiments. Significant differences *p < 0.05 vs. Control, #p < 0.05 vs. OGD. Related blots are shown in Supplementary Fig. S1. This change does not affect the conclusions of the Article.
  1 in total

1.  Serum and urine uric acid level may have different predictive value for urinary stone composition: a retrospective cohort study of 718 patients in Chinese population.

Authors:  Wen Wen; Yuehong Li; Qi Chen; Jianxing Li
Journal:  Int Urol Nephrol       Date:  2022-01-28       Impact factor: 2.266

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.